Graphic: Cathleen Heard |
![]() |
Some nongenotoxic compounds can become genotoxic following metabolic processing by the body. When an organism encounters an unnatural substance, referred to as a xenobiotic agent, ...
Graphic: Cathleen Heard Because most drugs undergo development and approval for seven to 10 years before coming to market, researchers are always looking for ways to speed the process. Preclinical drug testing involves both in vitro and animal assays that assess efficacy and potential side effects to predict how the agent will affect humans. Drug toxicity can result in such things as cancer and birth defects, so government agencies have set forth strict guidelines for toxicological testing. In p
Graphic: Cathleen Heard |
![]() |
Some nongenotoxic compounds can become genotoxic following metabolic processing by the body. When an organism encounters an unnatural substance, referred to as a xenobiotic agent, ...
A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.
View this IssueIn this webinar, Ethan Shelkey and Aurita Menezes will highlight key aspects in the design of cell-based assays.
Discover how alternative animal models provide new perspectives on physiological and biochemical processes.
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
Multiomics platform streamlines workflows and provides real-time insights, optimizing resource usage and ensuring smooth, data-driven operations
Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology designed to accelerate drug discovery and disease research with unprecedented scalability, reproducibility, and efficiency.
Learn how a target enrichment approach improves the discovery and characterization of viral pathogens.
Zymo Research is proud to introduce the Master the Microbiome Grant, a global initiative dedicated to advancing research in microbiomics, metagenomics, and microbial sciences.